Efficacy of Aspirin for primary prevention among adults with high-risk type 2 diabetes in the ACCORD trial.
Kazibwe R, Singleton M, Bancks MP, Namutebi J, Hammou A, Shapiro M, Yeboah J. Efficacy of Aspirin for primary prevention among adults with high-risk type 2 diabetes in the ACCORD trial. Diabetes Obes Metab. 2024 Jul 10.